Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Feasibility and yield of screening in relatives from familial pancreatic cancer families.

Ludwig E, Olson SH, Bayuga S, Simon J, Schattner MA, Gerdes H, Allen PJ, Jarnagin WR, Kurtz RC.

Am J Gastroenterol. 2011 May;106(5):946-54. doi: 10.1038/ajg.2011.65. Epub 2011 Apr 5.

2.

Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.

Langer P, Kann PH, Fendrich V, Habbe N, Schneider M, Sina M, Slater EP, Heverhagen JT, Gress TM, Rothmund M, Bartsch DK.

Gut. 2009 Oct;58(10):1410-8. doi: 10.1136/gut.2008.171611. Epub 2009 May 25.

PMID:
19470496
3.

Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.

Canto MI, Goggins M, Yeo CJ, Griffin C, Axilbund JE, Brune K, Ali SZ, Jagannath S, Petersen GM, Fishman EK, Piantadosi S, Giardiello FM, Hruban RH.

Clin Gastroenterol Hepatol. 2004 Jul;2(7):606-21.

PMID:
15224285
4.

Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.

Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Yeo C, Fishman EK, Brune K, Axilbund J, Griffin C, Ali S, Richman J, Jagannath S, Kantsevoy SV, Kalloo AN.

Clin Gastroenterol Hepatol. 2006 Jun;4(6):766-81; quiz 665. Epub 2006 May 6.

PMID:
16682259
5.

A clinical and economic evaluation of endoscopic ultrasound for patients at risk for familial pancreatic adenocarcinoma.

Rubenstein JH, Scheiman JM, Anderson MA.

Pancreatology. 2007;7(5-6):514-25. Epub 2007 Oct 1.

PMID:
17912015
6.

Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.

Kluijt I, Cats A, Fockens P, Nio Y, Gouma DJ, Bruno MJ.

J Clin Gastroenterol. 2009 Oct;43(9):853-7. doi: 10.1097/MCG.0b013e3181981123.

PMID:
19417680
7.

The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.

Poley JW, Kluijt I, Gouma DJ, Harinck F, Wagner A, Aalfs C, van Eijck CH, Cats A, Kuipers EJ, Nio Y, Fockens P, Bruno MJ.

Am J Gastroenterol. 2009 Sep;104(9):2175-81. doi: 10.1038/ajg.2009.276. Epub 2009 Jun 2.

PMID:
19491823
8.

Indications for endoscopic ultrasound and diagnosis on fine-needle aspiration and cytology.

Hussain T, Salamat A, Farooq MA, Hassan F, Hafeez M.

J Coll Physicians Surg Pak. 2009 Apr;19(4):223-7. doi: 04.2009/JCPSP.223227.

PMID:
19356336
9.

Pancreatic cancer--EUS and early diagnosis.

Helmstaedter L, Riemann JF.

Langenbecks Arch Surg. 2008 Nov;393(6):923-7. doi: 10.1007/s00423-007-0275-1. Epub 2008 Feb 5. Review.

PMID:
18247044
10.

Pancreatic cancer surveillance: learning as we go.

Brentnall TA.

Am J Gastroenterol. 2011 May;106(5):955-6. doi: 10.1038/ajg.2011.68.

PMID:
21540900
11.

Familial pancreatic cancer: challenging diagnostic approach and therapeutic management.

Mastoraki A, Chatzimavridou-Grigoriadou V, Chatzipetrou V, Mastoraki S, Papanikolaou IS, Danias N, Smyrniotis V, Arkadopoulos N.

J Gastrointest Cancer. 2014 Sep;45(3):256-61. doi: 10.1007/s12029-014-9609-8. Review.

PMID:
24756831
12.

Strategies for screening for pancreatic adenocarcinoma in high-risk patients.

Canto MI.

Semin Oncol. 2007 Aug;34(4):295-302. Review.

PMID:
17674957
13.

International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.

Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I, Nio Y, Schulick RS, Bassi C, Kluijt I, Levy MJ, Chak A, Fockens P, Goggins M, Bruno M; International Cancer of Pancreas Screening (CAPS) Consortium.

Gut. 2013 Mar;62(3):339-47. doi: 10.1136/gutjnl-2012-303108. Epub 2012 Nov 7. Erratum in: Gut. 2014 Dec;63(12):1978. Hammell, Pascal [corrected to Hammel, Pascal]. Gut. 2014 Jan;63(1):178. Hamell, Pascal [corrected to Hammell, Pascal].

14.

Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses.

Reicher S, Boyar FZ, Albitar M, Sulcova V, Agersborg S, Nga V, Zhou Y, Li G, Venegas R, French SW, Chung DS, Stabile BE, Eysselein VE, Anguiano A.

Pancreas. 2011 Oct;40(7):1057-62. doi: 10.1097/MPA.0b013e3182200201.

PMID:
21705950
15.
16.

Endoscopic ultrasound-guided fine needle aspiration of pancreatic masses: the utility and impact on management of patients.

Kliment M, Urban O, Cegan M, Fojtik P, Falt P, Dvorackova J, Lovecek M, Straka M, Jaluvka F.

Scand J Gastroenterol. 2010 Nov;45(11):1372-9. doi: 10.3109/00365521.2010.503966. Epub 2010 Jul 14.

PMID:
20626304
17.

Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma.

Eloubeidi MA, Jhala D, Chhieng DC, Chen VK, Eltoum I, Vickers S, Mel Wilcox C, Jhala N.

Cancer. 2003 Oct 25;99(5):285-92.

19.

CDKN2A germline mutations in familial pancreatic cancer.

Bartsch DK, Sina-Frey M, Lang S, Wild A, Gerdes B, Barth P, Kress R, Grützmann R, Colombo-Benkmann M, Ziegler A, Hahn SA, Rothmund M, Rieder H.

Ann Surg. 2002 Dec;236(6):730-7.

20.

Variation in precursor lesions of pancreatic cancer among high-risk groups.

Potjer TP, Schot I, Langer P, Heverhagen JT, Wasser MN, Slater EP, Klöppel G, Morreau HM, Bonsing BA, de Vos Tot Nederveen Cappel WH, Bargello M, Gress TM, Vasen HF, Bartsch DK; Leiden Familial Pancreatic Cancer Group; FaPaCa registry.

Clin Cancer Res. 2013 Jan 15;19(2):442-9. doi: 10.1158/1078-0432.CCR-12-2730. Epub 2012 Nov 21.

Items per page

Supplemental Content

Write to the Help Desk